Robert Stefanovich - Aug 19, 2025 Form 4 Insider Report for Cryoport, Inc. (CYRX)

Signature
/s/ Robert Stefanovich
Stock symbol
CYRX
Transactions as of
Aug 19, 2025
Transactions value $
-$295
Form type
4
Date filed
8/21/2025, 05:00 PM
Previous filing
Mar 26, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
STEFANOVICH ROBERT Chief Financial Officer C/O CRYOPORT INC., 112 WESTWOOD PLACE, SUITE 350, BRENTWOOD /s/ Robert Stefanovich 2025-08-21 0001247309

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYRX Common Stock Options Exercise $80.3K +26.2K +13.75% $3.07 217K Aug 19, 2025 Direct
transaction CYRX Common Stock Sale -$80.6K -9.3K -4.3% $8.67 207K Aug 19, 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYRX Options to purchase common stock Options Exercise $0 -26.2K -100% $0.00 0 Aug 19, 2025 Common Stock 26.2K $3.07 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The proceeds of the sale of Common Stock were used to pay the exercise price due upon the exercise of the Stock Option reported in this Form 4.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.60 to $8.75, inclusive.
F3 1/48 of the options vested on the 20th of each month for forty-eight months beginning on August 19, 2015.

Remarks:

With respect to prices reported as weighted average prices in Table I, the reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the applicable footnotes to this Form 4.